2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special…
By A. Camm, Gregory Y H Lip, R. De Caterina, I. Savelieva, D. Atar, S. Hohnloser, Gerhard Hindricks, P. Kirchhof. Europace, 2012
3,479 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/b7a6d3d69029719862371f23d87a2a3921099354
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- H. Calkins
- Vivek Y. Reddy
- R. Cappato
- D. Packer
- Young‐Hoon Kim
- J. Brugada
- P. Neužil
- Eduardo B. Saad
Citations in the corpus
- HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. (2014, unknown): “AF can be the presenting manifestation of CS.(68) Recent observational studies have reported a substantial prevalence of atrial arrhythmias in CS.”
- Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology). (2013, background): “Indeed, the recent 2012 European Society of Cardiology guidelines for AF management have, for the first time, included percutaneous LAA closure therapy for stroke prophylaxis in AF patientsdparticularly patients with contraindications to chronic anticoagulation therapy (26).”
- Cellular and Molecular Electrophysiology of Atrial Fibrillation Initiation, Maintenance, and Progression (2014, background): “Largely as a major risk factor for embolic stroke and worsening heart failure (HF), AF is associated with significant morbidity and mortality.(3) AF is classified as paroxysmal AF (pAF) when episodes last <7 days and spontaneously convert to normal sinus rhythm, persistent AF when lasting ≥7 days, o”
- 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation (2017, result): “These recommendations are consistent with the indications for AF ablation recommended in the recently published 2016 ESC guidelines for the management of AF as well as in the 2014 ACC/AHA/HRS Guidelines for AF management.(5,6,375,376) For patients with paroxysmal symptomatic AF who have not failed d”
- 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. (2014, unknown): “65 to74 years, Sex category (CHA2DS2-VASc) point score systems (Table 6) (16).”
- EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. (2016, unknown): “When AF persists, treatment is similar to that of non-DIAF patients.(133,134) Because of the wide range of mechanisms by which drugs cause AF, the histological changes associated with DIAF may vary substantially from EHRAS class I– IV (see Table 2 for reference).”